Literature DB >> 30061325

How placebo characteristics can influence estimates of intervention effects in trials.

Jeremy Howick1, Tammy Hoffmann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30061325      PMCID： PMC6066403          DOI： 10.1503/cmaj.171400

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  32 in total

1.  What's in placebos: who knows? Analysis of randomized, controlled trials.

Authors:  Beatrice A Golomb; Laura C Erickson; Sabrina Koperski; Deanna Sack; Murray Enkin; Jeremy Howick
Journal:  Ann Intern Med       Date:  2010-10-19       Impact factor: 25.391

Review 2.  Review of acupressure studies for chemotherapy-induced nausea and vomiting control.

Authors:  Jiyeon Lee; Marylin Dodd; Suzanne Dibble; Donald Abrams
Journal:  J Pain Symptom Manage       Date:  2008-04-28       Impact factor: 3.612

Review 3.  Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects.

Authors:  Fabrizio Benedetti; Elisa Carlino; Alessandro Piedimonte
Journal:  Lancet Neurol       Date:  2016-04-19       Impact factor: 44.182

4.  Paradox of placebo effect.

Authors:  B A Golomb
Journal:  Nature       Date:  1995-06-15       Impact factor: 49.962

5.  Influence of context effects on health outcomes: a systematic review.

Authors:  Z Di Blasi; E Harkness; E Ernst; A Georgiou; J Kleijnen
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

Review 6.  Does how you do depend on how you think you'll do? A systematic review of the evidence for a relation between patients' recovery expectations and health outcomes.

Authors:  M V Mondloch; D C Cole; J W Frank
Journal:  CMAJ       Date:  2001-07-24       Impact factor: 8.262

Review 7.  Placebo interventions for all clinical conditions.

Authors:  Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

8.  Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer.

Authors:  Pia Osterlund; Tarja Ruotsalainen; Katri Peuhkuri; Riitta Korpela; Anneli Ollus; Minna Ikonen; Heikki Joensuu; Inkeri Elomaa
Journal:  Clin Gastroenterol Hepatol       Date:  2004-08       Impact factor: 11.382

Review 9.  Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.

Authors:  Tom Jefferson; Mark Jones; Peter Doshi; Elizabeth A Spencer; Igho Onakpoya; Carl J Heneghan
Journal:  BMJ       Date:  2014-04-09

10.  Complements and the wound healing cascade: an updated review.

Authors:  Hani Sinno; Satya Prakash
Journal:  Plast Surg Int       Date:  2013-07-24
View more
  4 in total

1.  [Biosimilars and the nocebo effect].

Authors:  J Braun; S Tsiami; B Buehring; D Kiefer; I Andreica; X Baraliakos; U Kiltz
Journal:  Z Rheumatol       Date:  2020-04       Impact factor: 1.372

2.  Inadequate description of placebo and sham controls in a systematic review of recent trials.

Authors:  Rebecca K Webster; Jeremy Howick; Tammy Hoffmann; Helen Macdonald; Gary S Collins; Jonathan L Rees; Vitaly Napadow; Claire Madigan; Amy Price; Sarah E Lamb; Felicity L Bishop; Klara Bokelmann; Andrew Papanikitas; Nia Roberts; Andrea W M Evers
Journal:  Eur J Clin Invest       Date:  2019-09-30       Impact factor: 4.686

3.  Reporting quality of sham needles used as controls in acupuncture trials: a methodological evaluation.

Authors:  Ye-Seul Lee; Song-Yi Kim; Mariah Kim; Minseo Kim; Jiyoon Won; Hyangsook Lee; Myeong Soo Lee; Younbyoung Chae
Journal:  Chin Med       Date:  2022-05-31       Impact factor: 4.546

4.  PEER systematic review of randomized controlled trials: Management of chronic low back pain in primary care.

Authors:  Michael R Kolber; Joey Ton; Betsy Thomas; Jessica Kirkwood; Samantha Moe; Nicolas Dugré; Karenn Chan; Adrienne J Lindblad; James McCormack; Scott Garrison; G Michael Allan; Christina S Korownyk; Rodger Craig; Logan Sept; Andrew N Rouble; Danielle Perry
Journal:  Can Fam Physician       Date:  2021-01       Impact factor: 3.275
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.